Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-26-104164
Filing Date
2026-03-12
Accepted
2026-03-12 16:14:51
Documents
16
Effectiveness Date
2026-03-12

Document Format Files

Seq Description Document Type Size
1 S-8 bolt-20260312.htm S-8 178736
2 EX-5.1 bolt-ex5_1.htm EX-5.1 18060
3 EX-23.1 bolt-ex23_1.htm EX-23.1 3739
4 EX-FILING FEES bolt_exfilingfees.htm   iXBRL EX-FILING FEES 79714
5 GRAPHIC img38739919_0.gif GRAPHIC 1403
6 GRAPHIC img38739919_1.gif GRAPHIC 1403
  Complete submission text file 0001193125-26-104164.txt   433166

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT bolt_exfilingfees_htm.xml XML 17247
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-294245 | Film No.: 26747897
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)